REFERENCES
- Basquiera AL, Sembaj A, Aguerri AM, Omelianiuk M, Guzmán S, Moreno Barral J, Caeiro TF, Madoery RJ&, Salomone OA. (2003). Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction. Heart, 89, 1186–1190.
- Burgos JM, Diez M, Vigliano C, Bisio M, Risso M, Duffy T, Cura C, Bruses B, Favaloro L, Leguizamon MS, Lucero RH, Laguens R, Levin MJ, Favaloro R&, Schijman AG. (2010). Molecular identification of Trypanosoma cruzi discrete typing units in end-stage chronic Chagas heart disease reactivation after heart transplantation. Clinical Infectious Diseases, 51, 485–495.
- de Ayala AP, Pérez-Molina JA, Norman F&, López-Vélez R. (2009). Chagasic cardiomyopathy in immigrants from Latin America to Spain. Emerging Infectious Diseases, 15, 607–608.
- Duffy T, Bisio M, Altcheh J, Burgos JM, Diez M, Levin MJ, Favaloro RR, Freilij H&, Schijman AG. (2009). Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in Chagas disease patients. PLoS Neglected Tropical Diseases, 3, e419.
- Elias FE, Vigliano CA, Laguens RP, Levin MJ&, Berek C. (2003). Analysis of the presence of Trypanosoma cruzi in the heart tissue of three patients with chronic Chagas’ heart disease. American Journal of Tropical Medicine and Hygiene, 68, 242–247.
- Flores-Chavez M, Fernandez B, Puente S, Torres P, Rodriguez M, Monedero C, Cruz I, Garate T&, Cañavate C. (2008). Transfusional Chagas disease: parasitological and serological monitoring of an infected recipient and blood donor. Clinical Infectious Diseases, 46, e44–e47.
- Freitas JM, Lages-Silva E, Crema E, Pena SDJ&, Macedo AM. (2005). Real time PCR strategy for the identification of major lineages of Trypansoma cruzi directly in chronically infected human tissues. International Journal for Parasitology, 35, 411–417.
- Freitas JM, Augusto-Pinto L, Pimenta JR, Bastos-Rodrigues L, Goncalves VF, Teixeira SM, Chiari E, Junqueira AC, Fernández O, Macedo AM, Machado CR&, Pena SD. (2006). Ancestral genomes, sex and the population structure of Trypanosoma cruzi. PLoS Pathogens, 2, 226–235.
- Gascon J, Albajar P, Cañas E, Flores M, Gomez i Prat J, Herrera RN, Lafuente CA, Luciardi HL, Moncayo A, Molina L, Muñoz J, Puente S, Sanz G, Treviño B&, Sergio-Salles X. (2007). [Diagnosis, management and treatment of chronic Chagas’ heart disease in areas where Trypanosoma cruzi infection is not endemic]. Revista Espa ola de Cardiología, 60, 285–293.
- Gomes ML, Galvao LMC, Macedo AM, Pena SJ&, Chiari E. (1999). Chagas’ disease diagnosis: comparative analysis of parasitologic, molecular and serologic methods. American Journal of Tropical Medicine and Hygiene, 60, 205–210.
- Macedo AM&, Pena SDJ. (1998). Genetic variability of Trypanosoma cruzi: implication for the pathogenesis of Chagas’ disease. Parasitology Today, 14, 119–123.
- Ministerio de Sanidad y Consumo. (2005). Real Decreto 1088/2005 por el que se establecen los requisitos técnicos y condiciones mínimas de la hemodonación y de los centros y servicios de transfusión. In: Boletín Oficial del Estado. pp. 31288–31304. Madrid: Ministerio de Sanidad y Consumo.
- Pérez-Ayala A, Pérez-Molina JA, Norman F, Navarro M, Monge-Maillo B, Díaz-Menéndez M, Peris-García J, Flores M, Cañavate C&, López-Vélez R. (2011). Chagas disease in Latin American migrants: a Spanish challenge. Clinical Microbiology and Infection, 17, 1108–1113.
- Piron M, Fisa R, Casamitjana N, López-Chejade P, Puig L, Vergés M, Gascón J, Gómez i Prat J, Portús M&, Sauleda S. (2007). Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples. Acta Tropica, 103, 195–200.
- Rassi A, Rassi A&, Rasi SG. (2007). Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation, 115, 1101–1108.
- Schijman AG, Vigliano CA, Viotti RJ, Burgos JM, Brandariz S, Lococo BE, Leze MI, Armenti HA&, Levin MJ. (2004). Trypanosoma cruzi DNA in cardiac lesions of Argentinean patients with end-stage chronic Chagas heart disease. American Journal of Tropical Medicine and Hygiene, 70, 210–220.
- Sosa-Estani S, Viotti R&, Segura EL. (2009). Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina. Memórias do Instituto Oswaldo Cruz, 104 (Suppl. 1), 167–180.
- Valadares HM, Pimenta JR, de Freitas JM, Duffy T, Bartholomeu DC, Oliveira Rde P, Chiari E, Moreira Mda C, Filho GB, Schijman AG, Franco GR, Machado CR, Pena SD&, Macedo AM. (2008). Genetic profiling of Trypanosoma cruzi directly in infected tissues using nested PCR of polymorphic microsatellites. International Journal for Parasitology, 38, 839–850.
- World Health Organization (WHO). (2002). Control of Chagas disease: report of a WHO expert committee. WHO Technical Report Series, 905, 1–109.
- Zingales B, Andrade SG, Briones MRS, Campbell DA, Chairi E, Fernandes O, Guhl F, Lages-Silva E, Macedo AM, Machado CR, Miles MA, Romanha AJ, Sturm NR, Tibayrenc M&, Schijman AG. (2009). A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Memórias do Instituto Oswaldo Cruz, 104, 1051–1054.